Skip to content
Open access

Serum Albumin and Inflammation–Nutrition Burden in Adult Hospitalized Atopic Dermatitis: A Case–Control Study with Complementary Genetic Evidence

Oct 2026 · Clinical, Cosmetic and Investigational Dermatology · Vol 19, pp. 1-20 · 0 citations · 42 references
Medicine

TL;DR

Lower serum Alb was consistently associated with hospitalized adult AD status and may provide adjunctive information on systemic inflammation–nutrition burden in this inpatient setting and may provide adjunctive information on systemic inflammation–nutrition burden in this inpatient setting.

Abstract

Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that may involve systemic inflammation and metabolic disturbance. Serum albumin (Alb) is a routinely available negative acute-phase protein, but its association with hospitalized AD and sphingomyelin-related metabolic signals remains unclear. Methods This single-center retrospective case–control study included 814 adults (381 hospitalized patients with AD and 433 lipoma surgical inpatient controls). Alb was evaluated continuously, per standard-deviation increment, and by quartiles using multivariable logistic regression, restricted cubic splines, sensitivity analyses, and propensity-score matching. Two-sample Mendelian randomization (MR) provided complementary genetic evidence, and exploratory two-step MR examined a prespecified sphingomyelin-related phenotype. Results Alb was lower in patients with AD than in controls (38.9 ± 4.6 vs 41.2 ± 5.0 g/L; P<0.001). In the fully adjusted model, each 1-g/L increase in Alb was associated with lower odds of hospitalized AD status (OR=0.92, 95% CI: 0.89–0.96; P<0.001), with consistent findings across standardized, quartile, spline, sensitivity, and matched analyses. In the primary IVW analysis, genetically predicted higher Alb was associated with lower AD risk (OR=0.693, 95% CI: 0.519–0.926; P=0.013), whereas complementary MR estimates were not uniformly significant. Exploratory two-step MR showed associations of higher genetically predicted Alb with lower levels of the prespecified sphingomyelin-related phenotype and of higher sphingomyelin-related levels with greater AD risk. Conclusion Lower serum Alb was consistently associated with hospitalized adult AD status and may provide adjunctive information on systemic inflammation–nutrition burden in this inpatient setting. MR findings were supportive but not uniformly consistent, and the sphingomyelin analysis was exploratory rather than evidence of mediation. Prospective longitudinal studies incorporating standardized AD severity scores and serial Alb measurements are warranted.

Read PDF

Similar papers

Open access Sep 2026

Age-stratified correlations between atopic dermatitis severity and biomarkers: hypercoagulability as a key indicator of severity in older adults

The diagnostic utility of coagulation markers and eosinophil counts is age-dependent, and a practical, age-stratified clinical approach is suggested, particularly in elderly patients with moderate-to-severe AD.

Yi-Fan Zhang, Zheng-Hui Yang, Ying Zhao et al. · 0 citations
Open access Oct 2026

Serum Eosinophil Level Correlates With Atopic Dermatitis Severity: A Multicenter Cross‐Sectional Study in Chinese Patients With a Nested Cohort Analysis of Dupilumab Treatment Response

Personalized treatment strategies for atopic dermatitis (AD) are limited. Although serum total IgE (tIgE) and blood eosinophil levels are proposed biomarkers for AD severity, their clinical utility requires validation. We aimed to identify biomarkers reflecting AD severity and their association with dupilu...

Zhu-Ying Zhang, Jing-Wen Xue, Yi Zhao · 0 citations
Open access Oct 2026

Low Serum Adiponectin May Identify MASLD as a Comorbidity in Patients with Moderate-to-Severe Psoriasis

Purpose Psoriasis is an independent risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), a condition that frequently remains undetected in clinical routine diagnostics. We investigated whether routine laboratory parameters as well as serum adipokines and cytokines differ between psoriasis p...

L. Ackermann, A. Geier, M. Goebeler et al. · 0 citations
Oct 2026

Subclinical intestinal inflammation in psoriasis: a cross-sectional comparative study using fecal calprotectin.

BACKGROUND Psoriasis has been linked to inflammatory bowel disease and the gut-skin axis, but whether cutaneous psoriasis is associated with subclinical intestinal inflammation remains uncertain. OBJECTIVES To evaluate fecal calprotectin (FC) and gastrointestinal symptom burden in adults with psoriasis and controls,...

M. Marsak, S. Şener, Mehmet Enes Güner et al. · 0 citations
Open access Oct 2026

Serum vitamins and inflammatory bowel disease in children: a case-control study

Background Micronutrient deficiencies are common in pediatric inflammatory bowel disease (IBD), yet data on multiple vitamin profiles remain limited. This study aimed to comprehensively evaluate serum vitamin levels in children with IBD and explore their associations with immune cell profiles. Methods A retrospective o...

Xiao-Juan Li, Tie-Wei Li, Yue-Sheng Wang et al. · 0 citations
Open access Oct 2026

Nutritional-inflammatory and laboratory-derived fibrosis indices in FMF-related AA amyloidosis: associations with advanced kidney disease and mortality

Aims: Amyloid A (AA) amyloidosis is among the most serious systemic consequences of familial Mediterranean fever (FMF), particularly because of its renal burden. We investigated whether the fibrosis-4 index (FIB-4), the Aspartate Aminotransferase to-Platelet Ratio Index (APRI), HALP, and Prognostic Nutritional Index (P...

EC Bölek, Burak Karakaya, R. Kardaş et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.